Helius Medical Technologies (HSDT) Set to Announce Quarterly Earnings on Thursday

Helius Medical Technologies (NASDAQ:HSDTGet Rating) will be posting its quarterly earnings results before the market opens on Thursday, May 12th. Helius Medical Technologies has set its Q1 2022 guidance at EPS.

Helius Medical Technologies (NASDAQ:HSDTGet Rating) last posted its earnings results on Monday, March 14th. The company reported ($1.31) EPS for the quarter. The firm had revenue of $0.26 million for the quarter. Helius Medical Technologies had a negative return on equity of 198.39% and a negative net margin of 3,473.56%. On average, analysts expect Helius Medical Technologies to post $-4 EPS for the current fiscal year and $-3 EPS for the next fiscal year.

HSDT opened at $2.61 on Thursday. The business’s fifty day moving average is $3.28 and its two-hundred day moving average is $5.63. The company has a market cap of $9.91 million, a price-to-earnings ratio of -0.35 and a beta of 0.82. Helius Medical Technologies has a one year low of $2.53 and a one year high of $17.26.

Separately, Zacks Investment Research downgraded Helius Medical Technologies from a “buy” rating to a “hold” rating in a research report on Thursday, January 20th.

Helius Medical Technologies Company Profile (Get Rating)

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.

Read More

Earnings History for Helius Medical Technologies (NASDAQ:HSDT)

Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.